Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
RESEARCH TOOLSreports
Holding DE:9IP1?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | $ -600.00K | $ -800.00K | $ -600.00K | $ -700.00K | $ -500.00K |
| EBIT | $ -66.25M | $ -69.17M | $ -61.58M | $ -61.43M | $ -65.23M |
| EBITDA | $ -64.40M | $ -67.34M | $ -59.87M | $ -59.67M | $ -64.04M |
| Net Income Common Stockholders | $ -66.72M | $ -69.65M | $ -62.05M | $ -61.90M | $ -65.70M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 235.66M | $ 278.82M | $ 330.31M | $ 437.17M | $ 307.04M |
| Total Assets | $ 393.69M | $ 446.41M | $ 499.44M | $ 598.76M | $ 461.78M |
| Total Debt | $ 25.64M | $ 25.80M | $ 25.95M | $ 25.18M | $ 25.39M |
| Net Debt | $ -210.02M | $ -253.03M | $ -304.36M | $ -411.99M | $ -281.65M |
| Total Liabilities | $ 63.92M | $ 61.78M | $ 57.94M | $ 57.68M | $ 58.81M |
| Stockholders Equity | $ 329.77M | $ 384.63M | $ 441.50M | $ 541.09M | $ 402.97M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -53.69M | $ -55.75M | $ -58.89M | $ -61.80M | $ -54.98M |
| Operating Cash Flow | $ -52.10M | $ -53.82M | $ -56.86M | $ -57.15M | $ -50.87M |
| Investing Cash Flow | $ 78.92M | $ 55.62M | $ 35.03M | $ 48.25M | $ 31.21M |
| Financing Cash Flow | $ 176.00K | $ 1.53M | $ 1.18M | $ 189.49M | $ 182.00K |